Our approach demonstrates improved accuracy for detection of high-risk NF1 nerve sheath tumors that may undergo malignant transformation and it can be translated to the clinic for early diagnosis and possibly prevention of MPNST. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.